Creating engineered cell strains represents a critical method for analyzing gene activity and pathology processes. This report details the fundamental ideas behind generating conditional cell lines, addressing methods like CRISPR-Cas9, RNA interference (RNAi), and homologous recombination. Furthermore, we explore key considerations, including undes